Int. J. Mol. Sci. 2011, 12(9), 5895-5907; doi:10.3390/ijms12095895
Review

Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma

Department of Oncology, Cross Cancer Institute, School of Cancer, Imaging and Engineering Sciences, Faculty of Medicine and Dentistry, University of Alberta, 11560 University Avenue, Edmonton, Alberta, T6G 1Z2, Canada
* Authors to whom correspondence should be addressed.
Received: 5 August 2011; in revised form: 30 August 2011 / Accepted: 8 September 2011 / Published: 14 September 2011
(This article belongs to the Special Issue Biomarkers 2011)
PDF Full-text Download PDF Full-Text [182 KB, uploaded 14 September 2011 16:53 CEST]
Abstract: The incidence and mortality of pancreas cancer converge. There has been little advancement in the treatment of pancreas cancer since the acceptance of gemcitabine as the standard therapy. Unfortunately, the efficacy of gemcitabine is dismal. While there is much discussion for the development of biomarkers to help direct therapy in this area, there is little action to move them into clinical practice. Herein, we review potential pancreatic cancer biomarkers and discuss the limitations in their implementation.
Keywords: pancreatic adenocarcinoma; hENT1; hCNT3; SPARC; cDK; biomarker; clinical trials; gemcitabine; oxaliplatin

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Spratlin, J.L.; Mulder, K.E. Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma. Int. J. Mol. Sci. 2011, 12, 5895-5907.

AMA Style

Spratlin JL, Mulder KE. Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma. International Journal of Molecular Sciences. 2011; 12(9):5895-5907.

Chicago/Turabian Style

Spratlin, Jennifer L.; Mulder, Karen E. 2011. "Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma." Int. J. Mol. Sci. 12, no. 9: 5895-5907.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert